Page 1 of 1

#1

Posted: Thu Feb 05, 2026 1:21 pm
by RSS Post Bot
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a type of immune cell, undergo reprogramming when they come into contact with the tumor ecosystem and contribute to its progression. They then produce a molecule—the chemokine CCL3—which promotes cancer growth rather than fighting it. This mechanism appears to be a major variable in tumor biology and could serve as an indicator of disease progression. These findings are published in the journal Cancer Cell.

Source: https://medicalxpress.com/news/2026-02- ... ution.html